Item-level analyses reveal genetic heterogeneity in neuroticism

Abstract

Genome-wide association studies (GWAS) of psychological traits are generally conducted on (dichotomized) sums of items or symptoms (e.g., case-control status), and not on the individual items or symptoms themselves. We conduct large-scale GWAS on 12 neuroticism items and observe notable and replicable variation in genetic signal between items. Within samples, genetic correlations among the items range between 0.38 and 0.91 (mean rg = .63), indicating genetic heterogeneity in the full item set. Meta-analyzing the two samples, we identify 255 genome-wide significant independent genomic regions, of which 138 are item-specific. Genetic analyses and genetic correlations with 33 external traits support genetic differences between the items. Hierarchical clustering analysis identifies two genetically homogeneous item clusters denoted depressed affect and worry. We conclude that the items used to measure neuroticism are genetically heterogeneous, and that biological understanding can be gained by studying them in genetically more homogeneous clusters.

Leveraging mouse chromatin data for heritability enrichment informs common disease architecture and reveals cortical layer contributions to schizophrenia

“…rs11682175 achieves high PIPs with annotation in both loci (0.999 and 0.864 in rs75575209 and rs7596038, respectively) (Table S12). While not reported in the CLOZUK GWAS, rs11682175 has been significantly associated with major depression (Wray et al 2018), neuroticism (Nagel et al 2018), and schizophrenia (Schizophrenia Working Group of the Psychiatric Genomics Consortium 2014). This SNP, however, does not intersect with any OCRs in the cell populations studied.…”

Clustering by phenotype and genome-wide association study in autism

“…Traylor and colleagues (8) demonstrated that attempts to categorize patients with a complex disease into more homogeneous subgroups could have more power to elucidate the hidden heritability in a simulation study. Several studies on Alzheimer's disease, neuroticism, or asthma indicated that items or symptoms were to some degree more useful for identifying high-impact genetic factors than broadly defined diagnoses (9)(10)(11), although a study of ASD demonstrated modest effects of two-way stratification by individual symptoms (12). Additionally, medical researchers have begun to use machine learning methods (13), which is an artificial intelligence technique that can reveal masked patterns of data sets.…”

A randomized placebo‐controlled trial examining the effects of escitalopram on neuroticism and state anxiety in a nonclinical sample

“…EPQ neuroticism contains two factors: mood instability (rapid fluctuations between high and low mood/energy and sudden/frequent shifts into low mood) and trait anxiety (nervousness, worry, and features of social anxiety such as self-consciousness and hypersensitivity to negative evaluation; Loo, 1995;Mor et al, 2008;Peters, Bowen, & Balbuena, 2019;Roger & Morris, 1991). Results from a recent genome-wide association study suggest these factors are genetically distinct (Nagel, Watanabe, Stringer, Posthuma, & Sluis, 2018). Anxiety is well represented in the NEO-PI-R and the Zuckerman-Kuhlman Personality Questionnaire, although mood instability is not (Maples, Miller, Hoffman, & Johnson, 2014;Miller & Pilkonis, 2006;Miller, Vachon, & Lynam, 2009;Zuckerman, 2002).…”